The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections (Q36750086)

16 August 2017

1 reference

title

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections (English)

1 reference

16 August 2017

main subject

Pseudomonas aeruginosa

0 references

3

Marin H Kollef

1 reference

16 August 2017

James A Driscoll

1

1 reference

16 August 2017

Steven L Brody

series ordinal

2

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

67

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

351-368

1 reference

Bacteriological study of diabetic foot infections

16 August 2017

cites work

1 reference

12 December 2020

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

1 reference

12 December 2020

Guidelines for the prevention of intravascular catheter-related infections

1 reference

12 December 2020

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa

1 reference

12 December 2020

Pathogen-host interactions in Pseudomonas aeruginosa pneumonia

1 reference

12 December 2020

Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

12 December 2020

Changes of microbial flora and wound colonization in burned patients

1 reference

12 December 2020

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

12 December 2020

Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

1 reference

12 December 2020

Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control

1 reference

12 December 2020

Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment

1 reference

12 December 2020

Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.

1 reference

12 December 2020

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

1 reference

12 December 2020

Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland

1 reference

12 December 2020

Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study.

1 reference

12 December 2020

Outbreak of Sternal Surgical Site Infections Due to Pseudomonas aeruginosa Traced to a Scrub Nurse with Onychomycosis

1 reference

12 December 2020

Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection

1 reference

12 December 2020

Bacterial Biofilms: An Emerging Link to Disease Pathogenesis

1 reference

12 December 2020

Integrons and beta-lactamases--a novel perspective on resistance

1 reference

12 December 2020

In Vitro and In Vivo Antibacterial Activities of S-4661, a New Carbapenem

1 reference

12 December 2020

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 reference

12 December 2020

Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study

1 reference

12 December 2020

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world

1 reference

12 December 2020

Activities of doripenem (S-4661) against drug-resistant clinical pathogens

1 reference

12 December 2020

Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan

1 reference

12 December 2020

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

1 reference

12 December 2020

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

1 reference

12 December 2020

A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India

1 reference

12 December 2020

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

1 reference

12 December 2020

Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study

1 reference

12 December 2020

Protease IV, a Unique Extracellular Protease and Virulence Factor from Pseudomonas aeruginosa

1 reference

12 December 2020

Bacteriological profile and antibiotic resistance: comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center

1 reference

12 December 2020

Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.

1 reference

12 December 2020

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm

1 reference

12 December 2020

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

12 December 2020

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

1 reference

12 December 2020

Pseudomonas aeruginosa adherence to remodelling respiratory epithelium

1 reference

12 December 2020

Secretion of the Toxin ExoU Is a Marker for Highly VirulentPseudomonas aeruginosaIsolates Obtained from Patients with Hospital‐Acquired Pneumonia

1 reference

12 December 2020

An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker

1 reference

12 December 2020

In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients

1 reference

12 December 2020

Standards of care for patients with cystic fibrosis: a European consensus

1 reference

12 December 2020

Targeting mechanisms of Pseudomonas aeruginosa pathogenesis

1 reference

12 December 2020

Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee

1 reference

12 December 2020

P. aeruginosa quorum-sensing systems and virulence

1 reference

12 December 2020

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

12 December 2020

On the mechanism of solute uptake in Pseudomonas

1 reference

12 December 2020

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model

1 reference

12 December 2020

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

1 reference

12 December 2020

Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds

1 reference

12 December 2020

Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

1 reference

12 December 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

12 December 2020

Infectious complications in heart-lung transplantation. Analysis of 200 episodes

1 reference

12 December 2020

The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists

1 reference

12 December 2020

Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.

1 reference

12 December 2020

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

1 reference

12 December 2020

Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa

1 reference

12 December 2020

Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.

1 reference

12 December 2020

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

1 reference

12 December 2020

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

1 reference

12 December 2020

Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000.

1 reference

12 December 2020

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

1 reference

12 December 2020

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

1 reference

12 December 2020

Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study

1 reference

12 December 2020

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

12 December 2020

Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development

1 reference

12 December 2020

Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

1 reference

12 December 2020

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial

1 reference

12 December 2020

Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections

1 reference

12 December 2020

Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa

1 reference

12 December 2020

Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone

1 reference

12 December 2020

Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance

1 reference

12 December 2020

Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis

1 reference

12 December 2020

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

1 reference

12 December 2020

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis

1 reference

12 December 2020

Administration of aerosolized antibiotics in cystic fibrosis patients

1 reference

12 December 2020

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

1 reference

12 December 2020

Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey

1 reference

12 December 2020

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia

1 reference

12 December 2020

Bacterial etiology of diabetic foot infections in South India

1 reference

12 December 2020

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

1 reference

12 December 2020

Infection control and the prevention of nosocomial infections in the intensive care unit

1 reference

12 December 2020

The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo

1 reference

12 December 2020

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis

1 reference

12 December 2020

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

12 December 2020

Catheter-associated infections: pathogenesis affects prevention

1 reference

12 December 2020

Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care

1 reference

12 December 2020

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

12 December 2020

Modulation of lung epithelial functions by Pseudomonas aeruginosa

1 reference

12 December 2020

Nosocomial urinary tract infection: a microbiological study

1 reference

12 December 2020

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

1 reference

12 December 2020

Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.

1 reference

12 December 2020

Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital

1 reference

12 December 2020

Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control

1 reference

12 December 2020

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

1 reference

12 December 2020

Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis

1 reference

12 December 2020

Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth

1 reference

12 December 2020

Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis

1 reference

12 December 2020

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes

1 reference

12 December 2020

Pulmonary complications of HIV infection: autopsy findings

1 reference

12 December 2020

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

12 December 2020

Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact

1 reference

12 December 2020

A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting

1 reference

12 December 2020

Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates

1 reference

12 December 2020

Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

1 reference

12 December 2020

Overview of nosocomial infections caused by gram-negative bacilli

1 reference

12 December 2020

Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections

1 reference

12 December 2020

A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections

1 reference

12 December 2020

Cystic Fibrosis Adult Care

1 reference

12 December 2020

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

1 reference

12 December 2020

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

1 reference

12 December 2020

Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.

1 reference

12 December 2020

Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience

1 reference

12 December 2020

AmpC beta-lactamases: what do we need to know for the future?

1 reference

12 December 2020

Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation

1 reference

12 December 2020

Changes in the incidence and etiological patterns of bacteremia associated with acute leukemia over a 25-year period

1 reference

12 December 2020

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis

1 reference

12 December 2020

Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study

1 reference

12 December 2020

Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children

1 reference

12 December 2020

Surveillance of surgical site infections: decade of experience at a Colombian tertiary care center.

1 reference

12 December 2020

Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital

1 reference

12 December 2020

Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.

1 reference

12 December 2020

Nephrotoxicity of intravenous colistin: a prospective evaluation

1 reference

12 December 2020

Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis

1 reference

12 December 2020

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

1 reference

12 December 2020

Nosocomial infections in an Iranian burn care center

1 reference

12 December 2020

Strategies to prevent antimicrobial resistance in the intensive care unit

1 reference

12 December 2020

Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital

1 reference

12 December 2020

Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin

1 reference

12 December 2020

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

1 reference

12 December 2020

Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection

1 reference

12 December 2020

Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea

1 reference

12 December 2020

Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.

1 reference

12 December 2020

Results of the Spanish national nosocomial infection surveillance network (VICONOS) for surgery patients from January 1997 through December 2003

1 reference

12 December 2020

10.2165/00003495-200767030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1000478513

0 references

1 reference